Neural Correlates of Auriculotherapy
1 other identifier
interventional
10
1 country
1
Brief Summary
Chronic pain continues to be a major health issue, creating a significant societal burden, as it is an independent risk factor for opioid use disorder (OUD) and deaths. Acute pain episodes can often engender OUD due to lack of effective strategies to treat pain and prevent the transition to chronic pain. One potential non-opioid method for pain relief is auriculotherapy (AT), where acupuncture-like treatment is administered to the ear. The objective of this pilot study is to illustrate that AT-related brain effects can be found using functional connectivity MRI (fcMRI) in patients with low back pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 7, 2022
CompletedFirst Submitted
Initial submission to the registry
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedApril 10, 2024
April 1, 2024
1.3 years
April 4, 2024
April 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Default Mode Network (DMN)-to-Anterior Cingulate Cortex (ACC) connectivity
Group average difference in connectivity will be calculated as pre-treatment vs. post-treatment statistical contrasts. Connectivity change will have a threshold at the connection level with p \< 0.001. In this framework, a positive T-Score indicates greater connectivity before treatment (a decrease in connectivity after treatment).
Day 3 of participation
Secondary Outcomes (3)
Brief Pain Inventory (BPI) Severity Scores MRI #1
Day 3 of participation
BPI Pain Severity Scores MRI #2
Day 3 of participation
General Anxiety Disorder-7 (GAD-7) Scoring
Day 3 of participation
Study Arms (1)
Cryogenic Auriculotherapy Treatment
EXPERIMENTALCompressed nitrogen is used to create a 'cryogenic needle', using a cryopunctor device. An orifice is placed in appropriate acupoint and nitrogen flow is used to cool and activate the point. This will occur on each ear with the following points being targeted: Omega 2, Omega, spine location point, and 3 points of the pain pathway including the sensory master point (SMP), the master point of the reticule (MPR), and the thalamus (T) as well as the corpus callosum (CC) point, the amygdala, rhinencephalon, hippocampus, FSHLH, ACTH, anterior and posterior white commissure points, and the corresponding sympathetic sensory and motor nerve points.
Interventions
Compressed nitrogen is used to create a 'cryonic needle', using a cryopunctor device. An orifice is placed in appropriate acupoint and nitrogen flow is used to cool and activate the point.
Eligibility Criteria
You may qualify if:
- Age 18 and above.
- Experiencing low back pain for \> 1 month and seeking treatment.
- Literate for reading and writing in English, decision competent, willing and able to provide written informed consent, and able to complete the study's schedule of assessments.
You may not qualify if:
- Subjects under 18 years of age.
- History of claustrophobia.
- Having non-MRI safe metallic or foreign objects in their body.
- History of dementia.
- History of sensory or motor deficits that preclude participation in pain fMRI.
- History of clinically unstable systemic illness that is judged to interfere with the study.
- Pregnancy or the intent to become pregnant during the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC Montefiore
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Keith Vogt, MD, PhD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 4, 2024
First Posted
April 10, 2024
Study Start
July 15, 2021
Primary Completion
November 7, 2022
Study Completion
November 7, 2022
Last Updated
April 10, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
No plans to share this preliminary data.